“By working together, we hope to accelerate the discovery and clinical development of an important novel treatment. I am looking forward to working with a team that puts such an emphasis on open communication, long-term partnership, and shared success,” Kathryn Evans, General Manager, argenx Australia, said.
Australian first for argenx with autoimmune research partnership with UniSA
October 13, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Australia's 2026 flu vaccination season barely moves the needle on uptake
September 15, 2026 - - Latest News -
Persistent fatigue could be an overlooked sign of liver disease
September 15, 2026 - - Latest News -
Noxopharm moves lupus skin therapy toward next human trial
September 14, 2026 - - Australian Biotech -
Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends
September 14, 2026 - - Latest News -
Diabetes and cancer blood tests reach WA and NT patients under new Healius deal
September 14, 2026 - - Australian Biotech -
FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug
September 14, 2026 - - Australian Biotech -
Scandal-hit KPMG still holds $37 million in health department work
September 14, 2026 - - Latest News
